{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:18:20Z","timestamp":1789431500478,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lpm.2021.104073","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T17:09:21Z","timestamp":1632157761000},"page":"104073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Autoimmunity in lipodystrophy syndromes"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0701-642X","authenticated-orcid":false,"given":"Giovanni","family":"Ceccarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8705-6554","authenticated-orcid":false,"given":"Silvia","family":"Magno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9609-6286","authenticated-orcid":false,"given":"Donatella","family":"Gilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1706-0822","authenticated-orcid":false,"given":"Ferruccio","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2021.104073_bib0001","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4158\/endp.19.1.v767575m65p5mr06","article-title":"The clinical approach to the detection of lipodystrophy -an AACE consensus statement","volume":"19","author":"Handelsman","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.lpm.2021.104073_bib0003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J Endocrinol Investig"},{"issue":"18","key":"10.1016\/j.lpm.2021.104073_bib0004","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104073_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-020-1295-y","article-title":"European lipodystrophy registry: background and structure","volume":"15","author":"Von Schnurbein","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.lpm.2021.104073_bib0006","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"Feb","key":"10.1016\/j.lpm.2021.104073_bib0007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.lpm.2021.104073_bib0008","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(46)91599-1","article-title":"Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin","volume":"1","author":"Lawrence","year":"1946","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2021.104073_bib0009","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005792-200303000-00007","article-title":"Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature","volume":"82","author":"Misra","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2021.104073_bib0010","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/archderm.1987.01660360090018","article-title":"Lipoatrophic panniculitis: a possible autoimmune inflammatory disease of fat. Report of three cases","volume":"123","author":"Billings","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0011","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2021.104073_bib0012","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1016\/j.amjmed.2017.04.035","article-title":"Acquired generalized lipodystrophy following immune thrombocytopenia","volume":"130","author":"Cunningham","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2021.104073_bib0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4274\/jcrpe.v2i1.39","article-title":"Acquired generalized lipodystrophy associated with autoimmune hepatitis and low serum C4 level","volume":"2","author":"Eren","year":"2010","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.lpm.2021.104073_bib0014","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1210\/jc.2015-2589","article-title":"Oral EA. A report of three cases with acquired generalized lipodystrophy with distinct autoimmune conditions treated with metreleptin","volume":"100","author":"Lebastchi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0015","doi-asserted-by":"crossref","unstructured":"Ziegler J.F., B\u00f6ttcher C., Letizia M., Yerinde C., Wu H., Freise I., et\u00a0al. Leptin induces TNF\u03b1-dependent inflammation in acquired generalized lipodystrophy and combined Crohn's disease. 2019;10:5629.","DOI":"10.1038\/s41467-019-13559-7"},{"key":"10.1016\/j.lpm.2021.104073_bib0016","first-page":"1","article-title":"Acquired generalised lipodystrophy and type 1 diabetes mellitus in a child: a rare and implacable association","author":"Kumar","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.lpm.2021.104073_bib0017","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/jc.2007-1856","article-title":"Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy","volume":"93","author":"Park","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0018","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1210\/jc.2015-3722","article-title":"Progressive generalized lipodystrophy as a manifestation of autoimmune polyglandular syndrome type 1","volume":"101","author":"Sorkina","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.lpm.2021.104073_bib0019","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2018-00494","article-title":"Case report of acquired generalized lipodystrophy associated with common variable immunodeficiency","volume":"103","author":"Halpern","year":"2018","journal-title":"Case Rep J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2008-1703","article-title":"Complement abnormalities in acquired lipodystrophy revisited","volume":"94","author":"Savage","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0021","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semcdb.2017.12.017","article-title":"Complement as a diagnostic tool in immunopathology","volume":"85","author":"L\u00f3pez-Lera","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.lpm.2021.104073_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0029-1211955","article-title":"Dysregulation of insulin-like growth factors in a case of generalized acquired lipoatrophic diabetes mellitus (Lawrence Syndrome) connected with autoantibodies against adipocyte membranes","volume":"106","author":"H\u00fcbler","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.lpm.2021.104073_bib0023","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2005-0737","article-title":"Role of CD95-mediated adipocyte loss in autoimmune lipodystrophy","volume":"91","author":"Fischer-Posovszky","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0024","first-page":"1","article-title":"Autoantibodies against perilipin 1 as a cause of acquired generalized lipodystrophy","volume":"9","author":"Corvillo","year":"2018","journal-title":"Fron Immunol"},{"key":"10.1016\/j.lpm.2021.104073_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10428194.2015.1040015","article-title":"Lymphoma in acquired generalized lipodystrophy","volume":"57","author":"Brown","year":"2016","journal-title":"Case Rep Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.lpm.2021.104073_bib0026","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2013.04.014","article-title":"Adipokines in the HIV\/HAART-associated lipodystrophy syndrome","volume":"62","author":"Paruthi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.lpm.2021.104073_bib0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1297\/cpe.22.53","article-title":"Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy","volume":"22","author":"Adachi","year":"2013","journal-title":"Clin Pediatr. Endocrinol."},{"key":"10.1016\/j.lpm.2021.104073_bib0028","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/jc.2015-2476","article-title":"A novel syndrome of generalized lipodystrophy associated with pilocytic astrocytoma","volume":"100","author":"Patni","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0029","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1210\/jc.2018-02221","article-title":"Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma","volume":"104","author":"Kruschewsky Falcao","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00000441-188507000-00006","article-title":"Singular case of absence of adipose tissue matter in the upper half of the body","volume":"90","author":"Mitchell","year":"1885","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.lpm.2021.104073_bib0031","first-page":"1072","article-title":"Histoire clinique d'un cas d'atrophie du tissu celluloa- dipeux","volume":"6","author":"Barraquer","year":"1907","journal-title":"Neurol Zentralblatt"},{"key":"10.1016\/j.lpm.2021.104073_bib0032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02867054","article-title":"Eine seltene Trophoneurose (Lipodystrophia progressiva\u201c). Zeitschrift f\u00fcr die gesamte","volume":"5","author":"Simons","year":"1911","journal-title":"Neurol Psychiatr"},{"key":"10.1016\/j.lpm.2021.104073_bib0033","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.md.0000111061.69212.59","article-title":"Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature","volume":"83","author":"Misra","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.lpm.2021.104073_bib0034","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaad.2006.05.005","article-title":"Childhood acquired lipodystrophy: a retrospective study","volume":"55","author":"Pope","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.lpm.2021.104073_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13023-019-1292-1","article-title":"Immunological features of patients affected by Barraquer-Simons syndrome","volume":"15","author":"Corvillo","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.lpm.2021.104073_bib0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM197602262940902","article-title":"The complement abnormalities of lipodystrophy","volume":"294","author":"Sissons","year":"1976","journal-title":"New Engl J Med"},{"key":"10.1016\/j.lpm.2021.104073_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126608","article-title":"Complement Factor D (adipsin) levels are elevated in Barraquer-Simons syndrome","author":"Corvillo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lpm.2021.104073_bib0038","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1084\/jem.177.6.1827","article-title":"Complement mediated adipocyte lysis by nephritic factor sera","volume":"177","author":"Mathieson","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2021.104073_bib0039","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/1346-8138.15570","article-title":"Evidence of ongoing complement activation on adipose tissue from an 11-year-old girl with Barraquer-Simons syndrome","volume":"47","author":"Corvillo","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0040","doi-asserted-by":"crossref","first-page":"9210","DOI":"10.1016\/S0021-9258(19)50409-4","article-title":"Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue","volume":"267","author":"White","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2021.104073_bib0041","first-page":"617","article-title":"Acquired partial lipodystrophy associated with varicella","volume":"51","author":"Kurugol","year":"2009","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.lpm.2021.104073_bib0042","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000249208","article-title":"Partial lipodystrophy, meningoccal meningitis and nephritis","volume":"173","author":"Schifferli","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.lpm.2021.104073_bib0043","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.metabol.2015.06.004","article-title":"Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities","volume":"64","author":"Akinci","year":"2015","journal-title":"Metabolism"},{"key":"10.1016\/j.lpm.2021.104073_bib0044","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(00)02717-3","article-title":"Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood","volume":"356","author":"Taskinen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2021.104073_bib0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1464-5491.2006.01855.x","article-title":"Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease","volume":"23","author":"Rooney","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.lpm.2021.104073_bib0046","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/pbc.25601","article-title":"Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes","volume":"62","author":"Wei","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.lpm.2021.104073_bib0047","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1297\/cpe.26.99","article-title":"Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey","volume":"26","author":"Adachi","year":"2017","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/j.lpm.2021.104073_bib0048","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11764-020-00871-1","article-title":"Body composition after allogeneic haematopoietic cell transplantation\/total body irradiation in children and young people: a restricted systematic review","volume":"14","author":"Lorenc","year":"2020","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.lpm.2021.104073_bib0049","doi-asserted-by":"crossref","unstructured":"Tews D., Schulz A., Denzer C., von Schnurbein J., Ceccarini G., Debatin K.M., et\u00a0al. Lipodystrophy as a late effect after stem cell transplantation. 2021;8;10:1559.","DOI":"10.3390\/jcm10081559"},{"key":"10.1016\/j.lpm.2021.104073_bib0050","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40618-017-0731-x","article-title":"Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list","volume":"40","author":"Ceccarini","year":"2017","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.lpm.2021.104073_bib0051","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","article-title":"The role of B cells in the pathogenesis of graft-versus-host disease","volume":"114","author":"Shimabukuro-Vornhagen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2021.104073_bib0052","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13256-018-1901-y","article-title":"Acquired partial lipoatrophy as graft-versus-host disease and treatment with metreleptin: two case reports","volume":"12","author":"Shibata","year":"2018","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.lpm.2021.104073_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5269062","article-title":"Long-term survival, quality of life, and psychosocial outcomes in advanced melanoma patients treated with immune checkpoint inhibitors","volume":"2019","author":"Rogiers","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.lpm.2021.104073_bib0054","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104073_bib0055","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.2337\/dc18-2535","article-title":"Acquired generalized lipodystrophy: a new cause of anti-PD-1 immune-related diabetes","volume":"42","author":"Jehl","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lpm.2021.104073_bib0056","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bjd.18124","article-title":"Acquired generalized lipodystrophy under immune checkpoint inhibition","volume":"182","author":"Haddad","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0057","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/CMR.0000000000000660","article-title":"Acquired lipodystrophy associated with immune checkpoint inhibitors","volume":"30","author":"Gnanendran","year":"2020","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.lpm.2021.104073_bib0058","first-page":"e40","article-title":"A case of acquired generalized lipodystrophy associated with pembrolizumab in a patient with metastatic malignant melanoma","volume":"6","author":"Bedrose","year":"2020","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.lpm.2021.104073_bib0059","doi-asserted-by":"crossref","DOI":"10.3174\/ajnr.A7136","article-title":"Hypothalamic pilomyxoid astrocytoma in a child with lipodystrophy","author":"Benson","year":"2021","journal-title":"Am J Neuroradiol"},{"issue":"28","key":"10.1016\/j.lpm.2021.104073_bib0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1515\/jpem-2017-0222","article-title":"A novel paraneoplastic syndrome with acquired lipodystrophy and chronic inflammatory demyelinating polyneuropathy in an adolescent male with craniopharyngioma","volume":"31","author":"Lockemer","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0061","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.lpm.2021.104073_bib0062","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0190-9622(96)90673-8","article-title":"Localized involutional lipoatrophy: a clinicopathologic study of 16 patients","volume":"35","author":"Dahl","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0063","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4103\/0378-6323.55431","article-title":"Localized lipoatrophy after intramuscular amikacin","volume":"75","author":"Kumar","year":"2009","journal-title":"Indian J D ermatol Venereol Leprol"},{"key":"10.1016\/j.lpm.2021.104073_bib0064","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ad.2015.12.009","article-title":"Localized Lipoatrophy in a Boy After an Intramuscular Injection of Penicillin","volume":"107","author":"V\u00e1zquez-Osorio","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.lpm.2021.104073_bib0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/idoj.IDOJ_390_16","article-title":"Localized lipodystrophy following single dose intramuscular gentamycin injection","volume":"8","author":"Sharawat","year":"2017","journal-title":"Indian Dermatol Online J."},{"key":"10.1016\/j.lpm.2021.104073_bib0066","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/1346-8138.13635","article-title":"Localized involutional lipoatrophy at the site of an influenza vaccination: a case report","volume":"44","author":"Ninomiya","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0067","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/j.jaad.2013.09.038","article-title":"A case of lipoatrophy following quadrivalent human papillomavirus vaccine administration","volume":"70","author":"St\u00e9phan","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0068","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1365-4632.2007.03268.x","article-title":"DPT vaccine-induced lipoatrophy: an observational study","volume":"46","author":"Sardana","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.lpm.2021.104073_bib0069","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/adc.2010.183731","article-title":"Lipoatrophy with insulin analogues in type I diabetes","volume":"96","author":"Babiker","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.lpm.2021.104073_bib0070","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.diabres.2010.11.026","article-title":"Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus","volume":"91","author":"Peteiro-Gonz\u00e1lez","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.lpm.2021.104073_bib0071","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1210\/jc.2009-2773","article-title":"Lipoatrophy induced by subcutaneous insulin infusion: ultrastructural analysis and gene expression profiling","volume":"95","author":"Milan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104073_bib0072","doi-asserted-by":"crossref","unstructured":"Swelheim H.T., Westerlaken C., van Pinxteren-Nagler E., and Bocca G. Lipoatrophy in a girl with type 1 diabetes: beneficial effects of treatment with a glucocorticoid added to an insulin analog diabetes care. 2012; 35: e22.","DOI":"10.2337\/dc11-2135"},{"issue":"16","key":"10.1016\/j.lpm.2021.104073_bib0073","doi-asserted-by":"crossref","first-page":"bvab019","DOI":"10.1210\/jendso\/bvab019","article-title":"Effects of metreleptin on patient outcomes and quality of life in generalized and partial lipodystrophy","volume":"5","author":"Cook","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.lpm.2021.104073_bib0074","first-page":"dgab216","article-title":"Effect of leptin therapy on survival in generalized and partial lipodystrophy: a matched cohort analysis","volume":"2","author":"Cook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"28","key":"10.1016\/j.lpm.2021.104073_bib0075","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.EJ20-0325","article-title":"Metreleptin worked in a diabetic woman with a history of hematopoietic stem cell transplantation (HSCT) during infancy: further support for the concept of \u2018HSCT-associated lipodystrophy\u2019","volume":"68","author":"Adachi","year":"2021","journal-title":"Endocr. J."},{"key":"10.1016\/j.lpm.2021.104073_bib0076","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/17512433.2016.1096772","article-title":"Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy","volume":"9","author":"Meehan","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.lpm.2021.104073_bib0077","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s40519-019-00716-6","article-title":"Psychopathological and psychiatric evaluation of patients affected by lipodystrophy","volume":"25","author":"Calabr\u00f2","year":"2020","journal-title":"Eat Weight Disord"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:50Z","timestamp":1760105330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0755498221000129"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104073","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity in lipodystrophy syndromes","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104073"}}